(Q43688238)

25 November 2017

title

Effects of dopamine d2 receptor agonists in a pituitary transplantation-induced hyperprolactinaemia/anovulation model in rats (English)

1 reference

25 November 2017

Moro M

1

1 reference

25 November 2017

Inada Y

2

1 reference

25 November 2017

Miyata H

3

1 reference

25 November 2017

Komatsu H

4

1 reference

25 November 2017

Kojima M

5

1 reference

25 November 2017

Tsujii H

6

1 reference

25 November 2017

publication date

1 August 2001

1 reference

Clinical and Experimental Pharmacology and Physiology

25 November 2017

published in

1 reference

25 November 2017

volume

28

1 reference

25 November 2017

issue

8

1 reference

25 November 2017

page(s)

651-658

1 reference

Pregnancy outcome after treatment with the ergot derivative, cabergoline.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Hyperprolactinemic anovulatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Alteration of Feedback Mechanism of Estrogen on Gonadotropin by Sulpiride-Induced Hyperprolactinemia*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

In vivo interaction of cabergoline with rat brain dopamine receptors labelled with [3H]N-n-propylnorapomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Serum prolactin levels in rats with pituitary transplants or hypothalamic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Medical treatment of hyperprolactinaemic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

A double-blind study comparing a new non-ergot, long-acting dopamine agonist, CV 205-502, with bromocriptine in women with hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Effect of Prolactin on the Secretion of Hypothalamic GnRH and Pituitary Gonadotropins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Regulation of the tuberoinfundibular and nigrostriatal systems. Evidence for different kinds of dopaminergic neurons in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Effect of prolactin on dopamine synthesis in medial basal hypothalamus: evidence for a short loop feedback

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

Prolactin inhibition of estrogen production by cultured rat granulosa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

A possible role for prolactin in control of steroid secretion by the human Graafian follicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2001.03495.X

10.1046/J.1440-1681.2001.03495.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference